Hearing of board on effects of laetrile - Rules

N.D.C.C. § 23-23.1-03 — under Laetrile.

N.D.C.C. § 23-23.1-03

Any person may petition, or the board on its own motion may convene, a public hearing to determine the effects of the use of amygdalin and to promulgate rules and regulations pursuant to chapter 28-32 as to its use and administration.